3rd Quarter - Report — GILEAD SCIENCES, INC. for GILEAD SCIENCES INC (2012)

Firm

GILEAD SCIENCES, INC.

Client

GILEAD SCIENCES INC

Income

—

Expenses

$370,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Domestic HIV Policy issues: HIV Prevention; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding; Ryan White Program. Health Care Reform (Implementation of Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis Funding for Screening and Linkage to Care Programs; International HIV and Health issues; HIV/AIDS Technology Transfer and Patent Rights; International Trade and Intellectual Property Rights issues.

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—
REKHA RAMESH	—

Contacted: Commerce, Dept of (DOC); White House Office; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); U.S. Agency for International Development (USAID); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.